Rosett Max 4
4 · Immunome Inc. · Filed May 17, 2024
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Rosett Max
Chief Financial Officer
Transactions
- Award
Stock option (right to buy)
2024-05-16+30,000→ 30,000 totalExercise: $14.40Exp: 2034-05-15→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the options vest on May 16, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.